BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.560
0.00 (0.00%)
Oct 16, 2025, 9:12 AM EDT - Market open
BioCardia Market Cap
BioCardia has a market cap or net worth of $16.55 million as of October 16, 2025. Its market cap has increased by 51.47% in one year.
Market Cap
16.55M
Enterprise Value
16.31M
1-Year Change
51.47%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $16.55M, a decrease of -43.08%. That is a compound annual growth rate of -6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 16.55M | 65.60% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | 49.20M | 95.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |